1. Home
  2. CDIO vs GURE Comparison

CDIO vs GURE Comparison

Compare CDIO & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • GURE
  • Stock Information
  • Founded
  • CDIO 2017
  • GURE 2006
  • Country
  • CDIO United States
  • GURE China
  • Employees
  • CDIO N/A
  • GURE N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • GURE Major Chemicals
  • Sector
  • CDIO Health Care
  • GURE Industrials
  • Exchange
  • CDIO Nasdaq
  • GURE Nasdaq
  • Market Cap
  • CDIO 6.8M
  • GURE 5.6M
  • IPO Year
  • CDIO N/A
  • GURE 1992
  • Fundamental
  • Price
  • CDIO $3.71
  • GURE $4.16
  • Analyst Decision
  • CDIO
  • GURE
  • Analyst Count
  • CDIO 0
  • GURE 0
  • Target Price
  • CDIO N/A
  • GURE N/A
  • AVG Volume (30 Days)
  • CDIO 35.2K
  • GURE 97.0K
  • Earning Date
  • CDIO 11-14-2025
  • GURE 11-13-2025
  • Dividend Yield
  • CDIO N/A
  • GURE N/A
  • EPS Growth
  • CDIO N/A
  • GURE N/A
  • EPS
  • CDIO N/A
  • GURE N/A
  • Revenue
  • CDIO $19,507.00
  • GURE $13,919,011.00
  • Revenue This Year
  • CDIO $1,434.82
  • GURE N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • GURE N/A
  • P/E Ratio
  • CDIO N/A
  • GURE N/A
  • Revenue Growth
  • CDIO N/A
  • GURE N/A
  • 52 Week Low
  • CDIO $3.22
  • GURE $3.86
  • 52 Week High
  • CDIO $53.10
  • GURE $14.70
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 44.85
  • GURE 60.31
  • Support Level
  • CDIO $3.58
  • GURE $4.05
  • Resistance Level
  • CDIO $3.99
  • GURE $4.69
  • Average True Range (ATR)
  • CDIO 0.30
  • GURE 0.42
  • MACD
  • CDIO -0.04
  • GURE 0.03
  • Stochastic Oscillator
  • CDIO 24.48
  • GURE 65.67

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

Share on Social Networks: